272,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Gebundenes Buch

Examining the fastest growing sector in the biopharmaceutical market, this book discusses the advancement of protein drug development using peptides and proteins as the basis for prophylactic agents such as newly developed vaccines. As in the first two editions, this book employs a simple and straightforward style to discuss protein formulation and delivery from the basic to the more complex factors affecting protein stability and delivery. This third edition includes new information on insulin analogs, monoclonals, microneedles, and U.S. FDA guidelines.

Produktbeschreibung
Examining the fastest growing sector in the biopharmaceutical market, this book discusses the advancement of protein drug development using peptides and proteins as the basis for prophylactic agents such as newly developed vaccines. As in the first two editions, this book employs a simple and straightforward style to discuss protein formulation and delivery from the basic to the more complex factors affecting protein stability and delivery. This third edition includes new information on insulin analogs, monoclonals, microneedles, and U.S. FDA guidelines.
Autorenporträt
Ajay K. Banga is a professor and chair of the Department of Pharmaceutical Sciences at the College of Pharmacy and Health Sciences, Mercer University, Atlanta, Georgia. He obtained a PhD in pharmaceutics from Rutgers University, New Jersey. Dr. Banga is currently a major advisor to eight PhD students. He currently serves on the editorial board of eight journals and has also served as the Editor-in-Chief for one drug delivery journal. He has served on over 30 thesis/dissertation advisory committees and as a referee for more than 28 journals. Dr. Banga is a fellow of the American Association of Pharmaceutical Scientists. He has written more than 220 publications and scientific abstracts.